Massachusetts Financial Services CO Novartis Ag Transaction History

Massachusetts Financial Services CO

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$80.52 - $93.75 $1.27 Million - $1.48 Million	-15,776 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$80.11 - $90.62 $96,372 - $109,015	1,203 Added 8.25%	15,776 $1.38 Million
Q4 2021 Feb 10, 2022	BUY	$79.7 - $88.13 $1.16 Million - $1.28 Million	14,573 New	14,573 $1.28 Million
Q1 2020 May 14, 2020	SELL	$70.67 - $99.01 $10 Million - $14 Million	-141,625 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$84.35 - $95.37 $2.18 Million - $2.47 Million	-25,854 Reduced 15.44%	141,625 $13.4 Million
Q3 2019 Nov 05, 2019	SELL	$85.54 - $94.26 $82,888 - $91,337	-969 Reduced 0.58%	167,479 $14.6 Million
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $321,656 - $395,884	-4,266 Reduced 2.47%	168,448 $15.4 Million
Q1 2019 May 13, 2019	SELL	$75.32 - $86.15 $22,671 - $25,931	-301 Reduced 0.17%	172,714 $16.6 Million
Q4 2018 Feb 08, 2019	SELL	$73.66 - $82.02 $334,048 - $371,960	-4,535 Reduced 2.55%	173,015 $14.8 Million
Q3 2018 Oct 25, 2018	SELL	$66.94 - $77.43 $276,261 - $319,553	-4,127 Reduced 2.27%	177,550 $15.3 Million
Q2 2018 Jul 30, 2018	SELL	$64.91 - $73.36 $3,699 - $4,181	-57 Reduced 0.03%	181,677 $13.7 Million
Q1 2018 May 04, 2018	SELL	$70.39 - $84.15 $392,001 - $468,631	-5,569 Reduced 2.97%	181,734 $14.7 Million
Q4 2017 Feb 14, 2018	SELL	$72.33 - $77.64 $230,949 - $247,904	-3,193 Reduced 1.68%	187,303 $15.7 Million
Q3 2017 Nov 14, 2017	SELL	$74.14 - $77.27 $2.99 Million - $3.11 Million	-40,282 Reduced 17.45%	190,496 $16.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	230,778	230,778 $19.3 Million

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.